MedTrace Logo

Safety and Efficacy of the BTL-754 Device for Laser Skin Resurfacing Treatment of the Face

NCT06158438 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2024-11-14

No results posted yet for this study

Summary

This study will evaluate the clinical safety and the performance of the BTL-754 device (equipped with the 754-4 applicator) for reduction of facial wrinkles by the means of laser skin resurfacing treatment.

Conditions

  • Wrinkle

Interventions

DEVICE

BTL-754-4 Treatment

Treatment with the BTL-754 device with the BTL-754-4 applicator for reduction of facial wrinkles.

Sponsors & Collaborators

  • BTL Industries Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-16
Primary Completion
2024-06-07
Completion
2024-08-19

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06158438 on ClinicalTrials.gov